Gotowa bibliografia na temat „Cisplatin”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cisplatin”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Cisplatin"
Ozdemir-sanci, Tuba, and Ebru Alimogullari. "Effect of naringin and cisplatin combination on cell viability and cell death in bladder cancer cells." Journal of Research in Pharmacy 29, no. 2 (2025): 673–81. https://doi.org/10.12991/jrespharm.1664894.
Pełny tekst źródłaDemirel, Özge, and Serap Şahin. "Duloksetin Hidroklorür’ün DU-145 İnsan Prostat Kanser Hücreleri Üzerine Sitotoksik Etkisinin Araştırılması." Black Sea Journal of Health Science 8, no. 4 (2025): 132–38. https://doi.org/10.19127/bshealthscience.1649481.
Pełny tekst źródłaATAMAN, J. E., and D. BAXTER-GRILLO. "MORPHOLOGICAL EVALUATION OF CISPLATIN-INDUCED TESTICULAR DAMAGE IN WISTAR RATS." Nigerian Journal of Life Sciences (ISSN: 2276-7029) 4, no. 1 (2022): 16–25. http://dx.doi.org/10.52417/njls.v4i1.151.
Pełny tekst źródłaMonroe, Jerry D., Denis Hodzic, Matthew H. Millay, Blaine G. Patty, and Michael E. Smith. "Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin." Molecules 24, no. 21 (2019): 3889. http://dx.doi.org/10.3390/molecules24213889.
Pełny tekst źródłaHeiserman, James Patrick, Zenab Minhas, Elahe Nikpayam, and Dong-Joo Cheon. "Targeting Heat Shock Protein 27 and Fatty Acid Oxidation Augments Cisplatin Treatment in Cisplatin-Resistant Ovarian Cancer Cell Lines." International Journal of Molecular Sciences 24, no. 16 (2023): 12638. http://dx.doi.org/10.3390/ijms241612638.
Pełny tekst źródłaCHEN, PING, QING-SHENG WU, YA-PING DING, and ZI-CHUN ZHU. "PREPARATION OF CISPLATIN COMPOSITE MICRO/NANOFIBERS AND ANTITUMOR ACTIVITY IN VITRO AGAINST HUMAN TUMOR spc-a-1 CELLS." Nano 06, no. 04 (2011): 325–32. http://dx.doi.org/10.1142/s1793292011002688.
Pełny tekst źródłaMoon, Hyeon-Min, Jin-Sung Park, Il-Buem Lee, et al. "Cisplatin fastens chromatin irreversibly even at a high chloride concentration." Nucleic Acids Research 49, no. 21 (2021): 12035–47. http://dx.doi.org/10.1093/nar/gkab922.
Pełny tekst źródłaKarayay, Betül, Heidi Olze, and Agnieszka J. Szczepek. "Degranulation of Murine Resident Cochlear Mast Cells: A Possible Factor Contributing to Cisplatin-Induced Ototoxicity and Neurotoxicity." International Journal of Molecular Sciences 24, no. 5 (2023): 4620. http://dx.doi.org/10.3390/ijms24054620.
Pełny tekst źródłaBridget, SAMUEL1 Victor SAMUEL2* Otuamiobhedio Messiah WILFRED3 Victor Nnaemeka OGBONNA4 Igbanam Michael URANGIKOR5 Eugene ITIRI6 Emeka Emmanuel EZEALISIOBI7 Chinemerem Ulu IKPE8 Bliss ANYALEBECHI9 Benita Basil EGBE10. "CISPLATIN-INDUCED NEPHROTOXICITY IN WISTAR RATS." ISRG Journal of Clinical Medicine and Medical Research [ISRGJCMMR] II, no. II (2025): 5–9. https://doi.org/10.5281/zenodo.14955099.
Pełny tekst źródłaKasturi Pangarkar. "Development of cisplatin as an anti-cancer drug." GSC Advanced Research and Reviews 23, no. 1 (2025): 005–11. https://doi.org/10.30574/gscarr.2025.23.1.0101.
Pełny tekst źródłaRozprawy doktorskie na temat "Cisplatin"
Amaral, Catia Lira do. "Efeito do resveratrol na nefrotoxicidade induzida pela cisplatina em ratos." Universidade de São Paulo, 2006. http://www.teses.usp.br/teses/disponiveis/60/60134/tde-22052007-090133/.
Pełny tekst źródłaPan, Zhenrui. "Functional characterization of the GATOR1 complex in cisplatin resistance." Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASL053.
Pełny tekst źródłaSantos, Graciela Cristina dos [UNESP]. "Avaliação do efeito protetor do urucum e da bixina sobre a genotoxicidade induzida pelo antitumoral cisplatina em células da linhagem PC12." Universidade Estadual Paulista (UNESP), 2008. http://hdl.handle.net/11449/100973.
Pełny tekst źródłaSantos, Graciela Cristina dos. "Avaliação do efeito protetor do urucum e da bixina sobre a genotoxicidade induzida pelo antitumoral cisplatina em células da linhagem PC12 /." Araraquara : [s.n.], 2008. http://hdl.handle.net/11449/100973.
Pełny tekst źródłaKullmann, Maximilian [Verfasser]. "Identifying intracellular cisplatin interaction partners and assessing their contribution to cisplatin resistance / Maximilian Kullmann." Bonn : Universitäts- und Landesbibliothek Bonn, 2016. http://d-nb.info/111988876X/34.
Pełny tekst źródłaHadi, Sutopo. "The chemistry of cisplatin metabolites /." [St. Lucia, Qld.], 2007. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe19800.pdf.
Pełny tekst źródłaZhang, Jin-Gang. "Cisplatin nephrotoxicity : mechanisms and antidotes." Thesis, University of Liverpool, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.307635.
Pełny tekst źródłaCastro, João Humberto Teotônio de [UNESP]. "Avaliação do espermograma de cães submetidos à administração de cisplatina." Universidade Estadual Paulista (UNESP), 2007. http://hdl.handle.net/11449/89030.
Pełny tekst źródłaOliva, Carlos Alfredo Calpa [UNESP]. "Hemograma e teores séricos de Na, K, Mg, Ca e P de cães hígidos submetidos à administração de cisplatina." Universidade Estadual Paulista (UNESP), 2007. http://hdl.handle.net/11449/89087.
Pełny tekst źródłaLi, Yan Julia. "Cisplatin-induced cytotoxicity in MDCK cells." Thesis, University of Ottawa (Canada), 2002. http://hdl.handle.net/10393/6408.
Pełny tekst źródłaKsiążki na temat "Cisplatin"
Ozols, Robert F. High-dose Platinol (cisplatin for infection) in hypertonic saline. Bristol-Myers Oncology Division, 1985.
Znajdź pełny tekst źródłaYoshihiro, Kikuchi, ed. Mechanism of cisplatin resistance and its circumvention. Nova Science Publishers, 1998.
Znajdź pełny tekst źródłaChu, Wendy. Mechanism of cisplatin resistance inhuman malignant melanoma. National Library of Canada, 1998.
Znajdź pełny tekst źródłaMerazga, Yamina. Aspects of the interaction between cisplatin and renal glutathione. Brunel University, 1990.
Znajdź pełny tekst źródła1946-, Lippert Bernhard, ed. Cisplatin: Chemistry and biochemistry of a leading anticancer drug. Verlag Helvetica Chimica Acta, 1999.
Znajdź pełny tekst źródłaMorley, Christopher. Analogues of cisplatin from diamino carbohydrates and related compounds. University of East Anglia, 1986.
Znajdź pełny tekst źródłaEvans, Dyfed Llyr. The induction of apoptosis by the anticancer agent cisplatin. Universityof Manchester, 1994.
Znajdź pełny tekst źródłaLaurell, Göran. Ototoxicity of the anticancer drug cisplatin: Clinical and experimental aspects. Distributed by Almqvist & Wiksell Periodical Co., 1991.
Znajdź pełny tekst źródłaInstitut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Pembrolizumab (nicht kleinzelliges Lungenkarzinom: Nutzenbewertung gemäß § 35a SGB V. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, 2017.
Znajdź pełny tekst źródłaBryant, Eric Edward. Systems Genetics of DNA Damage Tolerance – Cisplatin, RAD5 & CRISPR-mediated Nonsense. [publisher not identified], 2019.
Znajdź pełny tekst źródłaCzęści książek na temat "Cisplatin"
Rosenberg, Barnett. "Platinum Complexes for the Treatment of Cancer: Why the Search Goes On." In Cisplatin. Verlag Helvetica Chimica Acta, 2006. http://dx.doi.org/10.1002/9783906390420.ch1.
Pełny tekst źródłaAno, Susan O., Zsuzsanna Kuklenyik, and Luigi G. Marzilli. "Structure and Dynamics of Pt Anticancer Drug Adducts from Nucleotides to Oligonucleotides as Revealed by NMR Methods." In Cisplatin. Verlag Helvetica Chimica Acta, 2006. http://dx.doi.org/10.1002/9783906390420.ch10.
Pełny tekst źródłaChen, Yu, Zijian Guo, and Peter J. Sadler. "195Pt- and 15N-NMR Spectroscopic Studies of Cisplatin Reactions with Biomolecules." In Cisplatin. Verlag Helvetica Chimica Acta, 2006. http://dx.doi.org/10.1002/9783906390420.ch11.
Pełny tekst źródłaBau, Robert, and Michal Sabat. "Structural Aspects of Pt-Purine Interactions: From Models to DNA." In Cisplatin. Verlag Helvetica Chimica Acta, 2006. http://dx.doi.org/10.1002/9783906390420.ch12.
Pełny tekst źródłaReedijk, Jan, and Jan Maarten Teuben. "Platinum-Sulfur Interactions Involved in Antitumor Drugs, Rescue Agents, and Biomolecules." In Cisplatin. Verlag Helvetica Chimica Acta, 2006. http://dx.doi.org/10.1002/9783906390420.ch13.
Pełny tekst źródłaAppleton, Trevor G. "Diammine- and Diamineplatinum Complexes with Non-Sulfur-Containing Amino Acids and Peptides." In Cisplatin. Verlag Helvetica Chimica Acta, 2006. http://dx.doi.org/10.1002/9783906390420.ch14.
Pełny tekst źródłaLippert, Bernhard. "Platinum Blues: On the Way toward Unraveling a Mystery." In Cisplatin. Verlag Helvetica Chimica Acta, 2006. http://dx.doi.org/10.1002/9783906390420.ch15.
Pełny tekst źródłaRandaccio, Lucio, and Ennio Zangrando. "Heteronuclear PtII Complexes with Pyrimidine Nucleobases." In Cisplatin. Verlag Helvetica Chimica Acta, 2006. http://dx.doi.org/10.1002/9783906390420.ch16.
Pełny tekst źródłaNatile, Giovanni, Francesco P. Intini, and Concetta Pacifico. "Diplatinum(III) Complexes: Chemical Species More Widely Spread Than Suspected." In Cisplatin. Verlag Helvetica Chimica Acta, 2006. http://dx.doi.org/10.1002/9783906390420.ch17.
Pełny tekst źródłaMatsumoto, Kazuko. "Inorganic and Organometallic Chemistry of Cisplatin-Derived Diplatinum(III) Complexes." In Cisplatin. Verlag Helvetica Chimica Acta, 2006. http://dx.doi.org/10.1002/9783906390420.ch18.
Pełny tekst źródłaStreszczenia konferencji na temat "Cisplatin"
Absar, Saheem, Mujibur Khan, Kyle Edwards, and David Calamas. "Electrospinning of Cisplatin-Loaded Cellulose Nanofibers for Cancer Drug Delivery." In ASME 2014 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2014. http://dx.doi.org/10.1115/imece2014-37182.
Pełny tekst źródłaCamargo, Luana Cristina, Joao Paulo Figueiro Longo, Karen Letycia Rodrigues de Paiva, Marina Mesquita Simões, Thais Bergmann, and Victor Carlos Mello da Silva. "Immunotherapy vaccines for triple-negative breast cancer and its influence on the tumor microenvironment." In Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1024.
Pełny tekst źródłaLau, KingWun. "Brief summary of cisplatin nephrotoxicity." In International Conference on Biological Engineering and Medical Science (ICBIOMed2022), edited by Gary Royle and Steven M. Lipkin. SPIE, 2023. http://dx.doi.org/10.1117/12.2669859.
Pełny tekst źródłaSoodvilai, Sirima, Sunhapas Soodvilai, Warayuth Sajomsang, Theerasak Rojanarata, Prasopchai Patrojanasophon, and Praneet Opanasopit. "Chitosan Polymeric Micelles for Prevention of Cisplatin-Induced Nephrotoxicity and Anticancer Activity of Cisplatin." In ICBET 2020: 2020 10th International Conference on Biomedical Engineering and Technology. ACM, 2020. http://dx.doi.org/10.1145/3397391.3397438.
Pełny tekst źródłaLee, Chunman, Masao Sasai, and Yoshiki Sawa. "Abstract 4452: Controlled release complex of cisplatin for mesothelioma: gamma-PGA/Cisplatin complex formulation." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-4452.
Pełny tekst źródłaLiang, Xiaobing, Michael D. Mueller, and Jing Jie Yu. "Abstract 2982: Activation of checkpoint kinase Chk2 by cisplatin and its role in cisplatin resistance." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-2982.
Pełny tekst źródłaAbdullah, N., N. Al Balushi, S. Al-Bahlani, et al. "EP765 The effect of malformina1 on cisplatin-sensitive and cisplatin-resistant ovarian cancer cell lines." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.816.
Pełny tekst źródłaLarisch, C., T. Markowiak, S. Golovchenko, et al. "Dosis-abhängige Cisplatin-Konzentration und -Eindringtiefe in humanes Lungengewebe bei Inkubation in hyperthermer Cisplatin-Lösung." In 32. Jahrestagung der Deutschen Gesellschaft für Thoraxchirurgie. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0043-1771119.
Pełny tekst źródłaGupta, Vikas, Ashok Kumar Chauhan, Paramjeet Kaur, Anil Khurana, Yashpal Verma, and Nupur Bansal. "Comparative evaluation of concomitant chemoradiation with weekly cisplatin and gemcitabine versus weekly cisplatin in the management of locally advanced carcinoma of uterine cervix." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685264.
Pełny tekst źródłaRichards, Elizabeth J., William O. Cookson, Sanjay Popat, and Miriam F. Moffatt. "Transcriptome Changes Accompanying Induced Cisplatin Resistance." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4918.
Pełny tekst źródłaRaporty organizacyjne na temat "Cisplatin"
Turchi, John J. Proteomic Analysis of Cisplatin-Resistant Ovarian Cancer. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada425620.
Pełny tekst źródłaTurchi, John. Proteomic Analysis of Cisplatin-Resistant Ovarian Concers. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada462560.
Pełny tekst źródłaTurchi, John J. Proteomic Analysis of Cisplatin-Resistant Ovarian Concers. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada463194.
Pełny tekst źródłaBalaji, Kethandapatti C. MT 2A Phosphorylation by PKC Mu/PKD Influences Chemosensitivity to Cisplatin in Prostate Cancer. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada495664.
Pełny tekst źródłaAllworth, Ann E. The Role of Terbium and Gadolinium in Reversal of Cisplatin Resistance in Cultured Human Breast Cancer Cells. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada414791.
Pełny tekst źródłaMiao, Fang, Yaru Guo, Yan Yuan, Juzhou Chen, and Yong Xin. Bevacizumab combined with pemetrexed plus carboplatin or cisplatin in the treatment of malignant pleural effusion of lung cancer : A meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.4.0096.
Pełny tekst źródłaWang, Dandan, Shuaihang Hu, Kangdi Cao, Chenxi Qiao, Zhuo Wang, and Wei Hou. Clinical efficacy and safety of Chinese herb injections combination with Docetaxel combined with cisplatin (DP) chemotherapy for advanced non-small cell lung cancer: A protocol for Bayesian network meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.9.0081.
Pełny tekst źródłaLi, Qian, Hua Xiao, Ren-long Liang, et al. Efficacy and safety of Cinobufacini injection combined with vinorelbine and cisplatin regimen chemotherapy for stage III/IV non-small cell lung cancer A protocol for systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.6.0091.
Pełny tekst źródłaParikh, Romil R., Alexander Troester, Bronwyn Southwell, et al. Treatment of Stages I–III Squamous Cell Anal Cancer: A Systematic Review. Agency for Healthcare Research and Quality (AHRQ), 2024. http://dx.doi.org/10.23970/ahrqepccer273.
Pełny tekst źródłaHealth hazard evaluation report: HETA-2009-0121-3106, evaluation of exposures to healthcare personnel from cisplatin during a mock interperitoneal operation, University Medical Center, Las Vegas, Nevada. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 2010. http://dx.doi.org/10.26616/nioshheta200901213106.
Pełny tekst źródła